Article Per Year (5 Year)
p-Index From 2020 - 2025
0.947
P-Index
This Author published in this journals
All Journal Jurnal Pendidikan dan Pembelajaran Khatulistiwa (JPPK) Jurnal Farmasi Klinik Indonesia Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) Jurnal Surya Medika Majalah Farmaseutik JFIOnline Indonesian Journal of Global Health research Jurnal Farmasi Sains dan Terapan (Journal of Pharmacy Science and Practice)
Widyati, Widyati
Rumah Sakit Angkatan Laut Dr. Ramelan, Surabaya
Biochemistry, Genetics & Molecular Biology Chemistry Decision Sciences, Operations Research & Management Education Health Professions Immunology & microbiology Languange, Linguistic, Communication & Media Mathematics Medicine & Pharmacology Nursing Public Health Other

Published : 12 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search
Journal : Jurnal Farmasi Klinik Indonesia

 1 
Peran Farmasis Klinis pada Pasien Gagal Ginjal Tahap Akhir dengan Hemodialisis Rahmatullah, Daril; Widyati, Widyati
Indonesian Journal of Clinical Pharmacy Vol 1, No 2 (2012)
Publisher : Indonesian Journal of Clinical Pharmacy

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (611.444 KB)

Abstract

Pasien gagal ginjal tahap akhir dengan hemodialisis merupakan populasi pasien dengan kondisi multipatologis dan multiterapi yang laju morbiditas serta mortalitasnya terus meningkat. Tujuan penelitian ini adalah untuk mengetahui peran farmasis klinis pada manajemen perkembangan penyakit gagal ginjal tahap akhir yang menggunakan terapi hemodialisis di Indonesia. Penelitian ini menggunakan metode kajian sistematis melalui penelusuran database penelitian. Penelitian yang terlibat terdiri atas 2 penelitian dengan metodologi ekperimental dan 8 metodologi deskriptif. Jenis peran farmasis klinis yang dilakukan adalah review catatan terapi (90%), evaluasi terapi (70%) dan implementasi terapi (20%). Penelitian yang ada telah memberikan gambaran mengenai peran farmasis klinis pada populasi pasien gagal ginjal dengan hemodialisis. Gambaran tersebut masih terbatas pada aktivitas pengkajian atau assessment. Hal ini karena penelitian yang berfokus pada peran farmasis klinis secara umum di Indonesia juga terbatas jumlahnya. Hasil penelitian ini menunjukkan bahwa peran farmasis klinis di Indonesia belum dapat dinilai kebermaknaannya.Kata kunci: Hemodialisis, gagal ginjal, farmasis klinis Clinical Pharmacist Roles On End-Stage Renal Disease Patient with HemodialysisAbstractEnd-stage renal disease with hemodialysis are considered as a multipathology and multitherapy patients which has an increase of morbidity and mortality rate. This research aim was to understand the roles of Indonesia clinical pharmacist, regarding to the subject with hemodialysis therapy. This study was a systematic review through research databases. The clinical pharmacist roles or activities ,which have beendone, were medical record review (9/10), therapeutic evaluation (7/10) and therapeutic implementation(2/10). All the studies have viewed clinical pharmacist activities on hemodialysis patient. Nonetheless the activities were only on assessment step which was actually an initial step. Limitation on quantity of this focused study on clinical pharmacist activitis on hemodialysis in Indonesia has been another constraint. The included studies have given an even more partial view due to lack of documentation on how the finding in the included research was being  assessed then followed as pharmacist care plan by the clinical pharmacist. The result of this study showed that clinical pharmacist role in Indonesia has not been yet defined its significance.Key words: Hemodialysis, renal failure, clinical pharmacist
Profil Penggunaan Antibiotik Pascapencanangan Penerapan Program Pengendalian Resistensi Antibiotik di Intensive Care Unit Rumah Sakit TNI-AL dr. Ramelan Surabaya Setiawan, Stefanie; Widyati, Widyati; Harijono, Pandu
Indonesian Journal of Clinical Pharmacy Vol 7, No 1 (2018)
Publisher : Indonesian Journal of Clinical Pharmacy

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (503.773 KB) | DOI: 10.15416/ijcp.2018.7.1.30

Abstract

Program Pengendalian Resistensi Antibiotik (PPRA) merupakan program wajib rumah sakit Indonesia sesuai Permenkes No. 8 tahun 2015. Rumkital dr. Ramelan Surabaya termasuk salah satu rumah sakit yang telah menerapkan PPRA. Tujuan penelitian ini adalah untuk mengetahui deskripsi kuantitatif-kualitatif pemakaian antibiotik, serta luaran klinis dan mikrobiologis yang teramati pascapencanangan penerapan PPRA di ICU Rumkital dr. Ramelan Surabaya. Desain penelitian adalah studi observasi cross-sectional yang dilakukan selama 3 bulan (Februari–Mei 2016) di ICU Rumkital dr. Ramelan. Deskripsi kuantitatif diamati menggunakan Days of Therapy (DOT/100 hari-pasien), deskripsi kualitatif menggunakan alur Gyssens. Pengamatan luaran klinis dilakukan terhadap infeksi nosokomial, mortalitas terkait infeksi, dan lama tinggal di ICU (Length of Stay/LOS). Pengamatan luaran mikrobiologis dilakukan terhadap pola penyebaran bakteri multiresisten. Hasil perhitungan jumlah konsumsi antibiotik didapatkan 151,63 DOT/100 hari-pasien. Penilaian kualitas antibiotik menunjukkan hasil 52,73% terapi tepat; 8,18% tidak tepat; 7,27% tanpa indikasi; 31,82% tidak tercapai kesepakatan antar penilai (κ=0,59; p<0,05). Infeksi nosokomial terbanyak yaitu Hospital Acquired Pneumonia (HAP)/Ventilator Associated Pneumonia (VAP), mortalitas terkait infeksi 44,68%; dan LOS rata-rata 7,17±1,9 hari (p<0,05). Belum ditemukan adanya insiden Methicillin-resistant Staphylococcus aureus (MRSA) ataupun Extended Spectrum Beta-Lactamase (ESBL), namun ditemukan dua kasus Multi Drug Resistant (MDR) Acinetobacter baumannii.Kata kunci: Alur Gyssens, DOT, ICU, PPRA, resistensi antibiotik Antibiotic Usage Profile after Antibiotic Stewardship Program Implementation in Intensive Care Unit of dr. Ramelan Naval Hospital SurabayaAntibiotic Stewardship Program (ASP) is mandatory to all Indonesian hospitals, in accordance to the 2015 Minister of Health Decree No. 8. Dr. Ramelan Naval Hospital Surabaya is one among the many hospitals in Indonesia that has implemented the ASP. The study objective was to describe quantitative-qualitatively the use of antibiotics, along with clinical and microbiological outcomes observed in an Intensive Care Unit (ICU) after ASP implementation in dr. Ramelan Naval Hospital Surabaya. The design was a 3-month (February–May 2016) cross-sectional observational study. Quantitative description was reported using Days of Therapy (DOT)/100 patient-days, the qualitative description was reviewed using Gyssens’ flowchart. Clinical outcomes observed include nosocomial infection, infection-related mortality, and average length of stay (LOS). Microbiological outcome was observed through the occurences of multi-drug resistant organism. The results showed overall antibiotic use was 151.63 DOT/100 patient-days. Quality of antibiotic use were 52.73% definitely appropriate; 8.18% inappropriate regarding dose, intervals, durations, and timing; 7.27% no indication; and no mutual agreement in 31.82% (κ=0.59; p<0.05). Hospital Acquired Pneumonias (HAPs)/Ventilator Associated Pneumonias (VAPs) were the most observed nosocomial infection, infection-related mortality rate was 44.68%; and average LOS were 7.17±1.9 days (p<0.05). No incidents of Methicillin-resistant Staphylococcus aureus (MRSA) or Extended Spectrum Beta-Lactamase (ESBL) have been found, but there were two cases of Multi Drug Resistant (MDR) Acinetobacter baumannii.Keywords: Antibiotic resistance, ASP, DOT, Gyssens’ flowchart, ICU
Peran Farmasis Klinis pada Pasien Gagal Ginjal Tahap Akhir dengan Hemodialisis Rahmatullah, Daril; Widyati, Widyati
Indonesian Journal of Clinical Pharmacy Vol 1, No 2 (2012)
Publisher : Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (611.444 KB)

Abstract

Pasien gagal ginjal tahap akhir dengan hemodialisis merupakan populasi pasien dengan kondisi multipatologis dan multiterapi yang laju morbiditas serta mortalitasnya terus meningkat. Tujuan penelitian ini adalah untuk mengetahui peran farmasis klinis pada manajemen perkembangan penyakit gagal ginjal tahap akhir yang menggunakan terapi hemodialisis di Indonesia. Penelitian ini menggunakan metode kajian sistematis melalui penelusuran database penelitian. Penelitian yang terlibat terdiri atas 2 penelitian dengan metodologi ekperimental dan 8 metodologi deskriptif. Jenis peran farmasis klinis yang dilakukan adalah review catatan terapi (90%), evaluasi terapi (70%) dan implementasi terapi (20%). Penelitian yang ada telah memberikan gambaran mengenai peran farmasis klinis pada populasi pasien gagal ginjal dengan hemodialisis. Gambaran tersebut masih terbatas pada aktivitas pengkajian atau assessment. Hal ini karena penelitian yang berfokus pada peran farmasis klinis secara umum di Indonesia juga terbatas jumlahnya. Hasil penelitian ini menunjukkan bahwa peran farmasis klinis di Indonesia belum dapat dinilai kebermaknaannya.Kata kunci: Hemodialisis, gagal ginjal, farmasis klinis Clinical Pharmacist Roles On End-Stage Renal Disease Patient with HemodialysisAbstractEnd-stage renal disease with hemodialysis are considered as a multipathology and multitherapy patients which has an increase of morbidity and mortality rate. This research aim was to understand the roles of Indonesia clinical pharmacist, regarding to the subject with hemodialysis therapy. This study was a systematic review through research databases. The clinical pharmacist roles or activities ,which have beendone, were medical record review (9/10), therapeutic evaluation (7/10) and therapeutic implementation(2/10). All the studies have viewed clinical pharmacist activities on hemodialysis patient. Nonetheless the activities were only on assessment step which was actually an initial step. Limitation on quantity of this focused study on clinical pharmacist activitis on hemodialysis in Indonesia has been another constraint. The included studies have given an even more partial view due to lack of documentation on how the finding in the included research was being  assessed then followed as pharmacist care plan by the clinical pharmacist. The result of this study showed that clinical pharmacist role in Indonesia has not been yet defined its significance.Key words: Hemodialysis, renal failure, clinical pharmacist
Co-Authors Agung Endro Nugroho Arrang, Sherly Tandi Fauzi, Rifani Giyantolin, Giyantolin Harijono, Pandu Ika Puspita Sari Lukman Hakim Putri, Cyndi Yulanda Rahmatullah, Daril Rahmatullah, Daril Regina Regina Sari, Juwita Permata Setiadi, Diga Albrian Setiawan, Stefanie Simorangkir, Timbul Partogi Haposan Soediatmoko, Soediatmoko Subiakto, Yuli Sutapa, Y. Gatot Yakti, Kuntjoro